Table 3.

Glycemic Outcomes

Glycemic outcomes	Median (IQR)
Age ≥18 (N = 2130)
% Time 70–180 mg/dL	70.1 (61.0–78.8)
% Time >180 mg/dL	28.6 (19.2–37.8)
% Time >250 mg/dL	6.3 (2.8–12.0)
% Time <70 mg/dL	1.1 (0.5–2.1)
% Time <54 mg/dL	0.2 (0.1–0.4)
Mean glucose	158.0 (144.5–172.6)
Age 14–17 (N = 412)
% Time 70–180 mg/dL	60.9 (50.1–71.8)
% Time >180 mg/dL	37.0 (26.5–48.7)
% Time >250 mg/dL	12.8 (6.1–21.9)
% Time <70 mg/dL	1.0 (0.5–1.9)
% Time <54 mg/dL	0.2 (0.1–0.4)
Mean glucose	171.4 (153.8–192.3)
Age 6–13 (N = 519)
% Time 70–180 mg/dL	61.2 (52.4–70.5)
% Time >180 mg/dL	37.2 (27.5–46.3)
% Time >250 mg/dL	12.7 (7.5–21.0)
% Time <70 mg/dL	1.1 (0.6–2.2)
% Time <54 mg/dL	0.2 (0.1–0.4)
Mean glucose	171.9 (156.5–189.6)
Overall (N = 3061)
% Time 70–180 mg/dL	67.3 (57.4–76.9)
% Time >180 mg/dL	31.4 (20.9–41.5)
% Time >250 mg/dL	8.0 (3.6–14.8)
% Time <70 mg/dL	1.1 (0.5–2.1)
% Time <54 mg/dL	0.2 (0.1–0.4)
Mean glucose	161.7 (147.3–178.6)

Glycemic outcomes for each age cohort and overall with 12 months of Control-IQ technology use.